| 标题 |
Targeting TROP-2 In Diffuse Pleural Mesothelioma
TROP-2靶向治疗弥漫性胸膜间皮瘤
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 |
M.D. Offin , S. Tischfield , P. Manoj , P. Agrawal , S. Tendler , E.C. Pratt , W. Travis , A. Rimner , C.B. Simone , E. de Stanchina , J. Qiu , V. Markov , M. Donoghue , J.S. Lewis , M.G. Kris , J.L. Sauter , P.S. Adusumilli , C.M. Rudin , A. Quintanal Villalonga , M.G. Zauderer Show more Add to Mendeley Share Cite https://doi.org/10.1016/j.jtho.2024.09.125 Get rights and content Introduction Diffuse pleural mesothelioma (DPM) is a nearly universally fatal malignancy with limited treatment options. There is a lack of validated biomarkers, other than histology, and no approved targeted strategies. Utilizing our patient derived xenograft (PDX) library, we identified TROP-2 as a candidate target. TROP-2 expression has been shown to correlate with tumorigenesis in several solid tumors but has not been adequately assessed in DPM. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)